VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer

Incidents per State

State Total
92,076
AK1,880
AL6,345
AR4,151
AS46
AZ14,991
CA66,887
CO12,550
CT8,943
DC1,795
DE2,009
FL42,724
FM4
GA17,031
GU124
HI2,580
IA4,919
ID2,892
IL22,128
IN24,197
KS5,047
KY9,111
LA5,500
MA15,718
MD13,434
ME3,351
MH8
MI20,971
MN13,585
MO10,747
MP30
MS3,198
MT2,477
NC18,051
ND1,501
NE3,109
NH3,218
NJ20,216
NM4,218
NV4,728
NY37,667
OH20,793
OK6,692
OR9,244
PA25,607
PR2,588
QM2
RI2,163
SC7,261
SD1,282
TN10,445
TX39,890
UT4,618
VA15,980
VI67
VT1,830
WA16,071
WI12,042
WV2,571
WY926
XB5
XL1
XV2

ID: 1565196
Sex: M
Age: 66
State: NM

Vax Date: 02/19/2021
Onset Date: 02/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: This spontaneous case was reported by a physician and describes the occurrence of MALAISE (Malaise), VACCINATION SITE INDURATION (Tenderness at injection site), FATIGUE (Generalize fatigue) and VACCINATION SITE SWELLING (Swelling at injection site) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for an unknown indication. No Medical History information was reported. On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced VACCINATION SITE INDURATION (Tenderness at injection site), FATIGUE (Generalize fatigue) and VACCINATION SITE SWELLING (Swelling at injection site). On an unknown date, the patient experienced MALAISE (Malaise). At the time of the report, MALAISE (Malaise), VACCINATION SITE INDURATION (Tenderness at injection site), FATIGUE (Generalize fatigue) and VACCINATION SITE SWELLING (Swelling at injection site) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1565197
Sex: F
Age: 75
State: NJ

Vax Date: 03/10/2021
Onset Date: 03/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: blood pressure high compared to normal; heart pounding faster than usual; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (blood pressure high compared to normal) and HEART RATE INCREASED (heart pounding faster than usual) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. No medical history was provided by the reporter. On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced HYPERTENSION (blood pressure high compared to normal) and HEART RATE INCREASED (heart pounding faster than usual). At the time of the report, HYPERTENSION (blood pressure high compared to normal) and HEART RATE INCREASED (heart pounding faster than usual) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, Blood pressure measurement: 160/88 mmHg (High) 160/88. On 10-Mar-2021, Heart rate: 93 beats per minute (High) 93. In March 2021, Blood pressure measurement: 142/87 mmHg (Inconclusive) 142/87. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication includes antidepressant medications and sleeping medications. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1565198
Sex: F
Age: 69
State: WA

Vax Date: 02/03/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for COVID-19). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for COVID-19) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications was reported Treatment information was not provided Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: Additional information added

Other Meds:

Current Illness:

ID: 1565199
Sex: M
Age: 69
State: NY

Vax Date: 03/10/2021
Onset Date: 03/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Feet are both swollen, left foot more than usual; feet and he uses walker but now they are so swollen and unbearable; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Feet are both swollen, left foot more than usual) and PAIN IN EXTREMITY (feet and he uses walker but now they are so swollen and unbearable) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044M20A) for COVID-19 vaccination. Concurrent medical conditions included Leg deformity NOS (Patient uses walker.) and Walker user. On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PERIPHERAL SWELLING (Feet are both swollen, left foot more than usual) and PAIN IN EXTREMITY (feet and he uses walker but now they are so swollen and unbearable). At the time of the report, PERIPHERAL SWELLING (Feet are both swollen, left foot more than usual) and PAIN IN EXTREMITY (feet and he uses walker but now they are so swollen and unbearable) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided.

Other Meds:

Current Illness: Leg deformity NOS (Patient uses walker.); Walker user

ID: 1565200
Sex: F
Age: 72
State:

Vax Date: 02/24/2021
Onset Date: 03/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Vaccination site warmth; Vaccination site rash; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE WARMTH (Vaccination site warmth) and VACCINATION SITE RASH (Vaccination site rash) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. Concomitant products included GLIPIZIDE, LISINOPRIL, METFORMIN, SIMVASTATIN, VERAPAMIL HYDROCHLORIDE (ISOPTIN DC) and AMLODIPINE for an unknown indication. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Vaccination site warmth) and VACCINATION SITE RASH (Vaccination site rash). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Vaccination site warmth) and VACCINATION SITE RASH (Vaccination site rash) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment information included ice application.

Other Meds: GLIPIZIDE; LISINOPRIL; METFORMIN; SIMVASTATIN; ISOPTIN DC; AMLODIPINE

Current Illness:

ID: 1565201
Sex: M
Age: 64
State: NY

Vax Date: 03/04/2021
Onset Date: 03/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Severe wheezing which began in his sleep; This spontaneous case was reported by a consumer and describes the occurrence of WHEEZING (Severe wheezing which began in his sleep) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced WHEEZING (Severe wheezing which began in his sleep). At the time of the report, WHEEZING (Severe wheezing which began in his sleep) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication was reported. Treatment medication was not provided by the reporter. The patient's wife stated that it sounded as if the patient had an upper respiratory infection. The patient was wheezing so severely that it resulted in him using his wife's oxygen machine to continue breathing. The patient had an appointment on Thursday 11-MAR-2021 with his healthcare provider. Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.

Other Meds:

Current Illness:

ID: 1565202
Sex: F
Age:
State: CA

Vax Date: 03/04/2021
Onset Date: 03/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Had a bad accident and fell; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and FALL (Had a bad accident and fell) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On an unknown date, the patient experienced FALL (Had a bad accident and fell). At the time of the report, PAIN IN EXTREMITY (Sore arm) and FALL (Had a bad accident and fell) outcome was unknown. No concomitant medications was reported Treatment information was not provided

Other Meds:

Current Illness:

ID: 1565203
Sex: F
Age: 74
State: IN

Vax Date: 03/03/2021
Onset Date: 03/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: More short of breath and having to use the inhaler more; Muscle aches; Chills; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (More short of breath and having to use the inhaler more), MYALGIA (Muscle aches) and CHILLS (Chills) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. Concurrent medical conditions included Asthma. On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced MYALGIA (Muscle aches) and CHILLS (Chills). On an unknown date, the patient experienced DYSPNOEA (More short of breath and having to use the inhaler more). On 05-Mar-2021, CHILLS (Chills) had resolved. On 06-Mar-2021, MYALGIA (Muscle aches) had resolved. At the time of the report, DYSPNOEA (More short of breath and having to use the inhaler more) outcome was unknown. No concomitant medications was reported Treatment information was not provided Action taken with mRNA-1273 in response to the event was Not Applicable

Other Meds:

Current Illness:

ID: 1565204
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: had a sore arm after getting the vaccine; This spontaneous case was reported by a non-health professional and describes the occurrence of VACCINATION SITE PAIN (had a sore arm after getting the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (had a sore arm after getting the vaccine). At the time of the report, VACCINATION SITE PAIN (had a sore arm after getting the vaccine) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication and treatment drug were not reported.

Other Meds:

Current Illness:

ID: 1565205
Sex: F
Age: 75
State: WV

Vax Date: 03/10/2021
Onset Date: 03/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: toes started hurting. It was swollen, painful; toes started hurting. It was swollen, painful; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (toes started hurting. It was swollen, painful) and SWELLING (toes started hurting. It was swollen, painful) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. No Medical History information was reported. On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY (toes started hurting. It was swollen, painful) and SWELLING (toes started hurting. It was swollen, painful). At the time of the report, PAIN IN EXTREMITY (toes started hurting. It was swollen, painful) and SWELLING (toes started hurting. It was swollen, painful) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications was reported Treatment information was not provided

Other Meds:

Current Illness:

ID: 1565206
Sex: F
Age: 53
State: NJ

Vax Date: 02/28/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Delayed skin reaction; Below the injection site which was hot to the touch; Red rash on her arm below the injection site; Below the injection site which was swollen; Below the injection site which was itching; This spontaneous case was reported by a consumer and describes the occurrence of SKIN REACTION (Delayed skin reaction), VACCINATION SITE WARMTH (Below the injection site which was hot to the touch), VACCINATION SITE RASH (Red rash on her arm below the injection site), VACCINATION SITE SWELLING (Below the injection site which was swollen) and VACCINATION SITE PRURITUS (Below the injection site which was itching) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. No Medical History information was reported. On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SKIN REACTION (Delayed skin reaction), VACCINATION SITE WARMTH (Below the injection site which was hot to the touch), VACCINATION SITE RASH (Red rash on her arm below the injection site), VACCINATION SITE SWELLING (Below the injection site which was swollen) and VACCINATION SITE PRURITUS (Below the injection site which was itching). At the time of the report, SKIN REACTION (Delayed skin reaction), VACCINATION SITE WARMTH (Below the injection site which was hot to the touch), VACCINATION SITE RASH (Red rash on her arm below the injection site), VACCINATION SITE SWELLING (Below the injection site which was swollen) and VACCINATION SITE PRURITUS (Below the injection site which was itching) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication was reported. Treatment medication was not provided by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Delayed skin reaction and Vaccination site warmth added as new event. Lower level term updated for all existing events.

Other Meds:

Current Illness:

ID: 1565207
Sex: F
Age: 69
State:

Vax Date: 03/08/2021
Onset Date: 03/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: I felt muscles in my knees again.; My knees gave out on me and I fell to the floor; A spontaneous report was received from a 69-years-old female patient concerning herself who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events knees gave out and fell to the floor. The patient's medical history was not provided. No relevant concomitant medications were reported. On unknown date in Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 030L20A) intramuscularly for prophylaxis of COVID-19 infection. On 8 Mar 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: 022M20A) intramuscularly for prophylaxis of COVID-19 infection. On 9 Mar 2021, the patient experienced the event knees gave out and fell to the floor. Treatment details was not reported. Action taken with mRNA-1273 in response to the events was not reported. The outcome of event knees gave out and fell to the floor was unknown.

Other Meds:

Current Illness: Hepatic disease NOS

ID: 1565208
Sex: F
Age: 71
State: CO

Vax Date: 01/27/2021
Onset Date: 03/02/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Tiny Blisters on belly , breast and back; Felt itchy on all around her shoulders and neck; Fever; Chills; headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BLISTER (Tiny Blisters on belly , breast and back), PRURITUS (Felt itchy on all around her shoulders and neck), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (headache) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 032L20A) for COVID-19 vaccination. Patient's medical history included No Adverse event. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced PYREXIA (Fever), CHILLS (Chills) and HEADACHE (headache). On 05-Mar-2021, the patient experienced PRURITUS (Felt itchy on all around her shoulders and neck). On 08-Mar-2021, the patient experienced BLISTER (Tiny Blisters on belly , breast and back). The patient was treated with CORTISONE at an unspecified dose and frequency. On 04-Mar-2021, PYREXIA (Fever), CHILLS (Chills) and HEADACHE (headache) had resolved. At the time of the report, BLISTER (Tiny Blisters on belly , breast and back) and PRURITUS (Felt itchy on all around her shoulders and neck) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1565209
Sex: F
Age: 65
State: CO

Vax Date: 02/27/2021
Onset Date: 03/08/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Itching on arm where vaccine was given; Welt on arm where vaccine was given; Red where vaccine was given; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching on arm where vaccine was given), VACCINATION SITE URTICARIA (Welt on arm where vaccine was given) and INJECTION SITE ERYTHEMA (Red where vaccine was given) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. Patient's medical history included No Adverse event. On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itching on arm where vaccine was given), VACCINATION SITE URTICARIA (Welt on arm where vaccine was given) and INJECTION SITE ERYTHEMA (Red where vaccine was given). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. On 11-Mar-2021, VACCINATION SITE PRURITUS (Itching on arm where vaccine was given) and VACCINATION SITE URTICARIA (Welt on arm where vaccine was given) had resolved. At the time of the report, INJECTION SITE ERYTHEMA (Red where vaccine was given) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications was reported

Other Meds:

Current Illness:

ID: 1565210
Sex: F
Age:
State: CA

Vax Date: 03/10/2021
Onset Date: 03/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: sore arm; chest tightness; muscle pain; chills; nausea; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), CHEST DISCOMFORT (chest tightness), MYALGIA (muscle pain), CHILLS (chills) and NAUSEA (nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm), CHEST DISCOMFORT (chest tightness), MYALGIA (muscle pain), CHILLS (chills), NAUSEA (nausea) and HEADACHE (headache). At the time of the report, PAIN IN EXTREMITY (sore arm), CHEST DISCOMFORT (chest tightness), MYALGIA (muscle pain), CHILLS (chills), NAUSEA (nausea) and HEADACHE (headache) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Heart rate: high (High) pulse 98-104 (usually 60s). Treatment information not provided. Concomitant medications were not provided. This case was linked to MOD-2021-210746 (Patient Link).

Other Meds:

Current Illness:

ID: 1565211
Sex: F
Age: 52
State: MD

Vax Date: 02/04/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: itching the injection site and it was a little red mark, had a knot; itching the injection site; a little red at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE NODULE (itching the injection site and it was a little red mark, had a knot), VACCINATION SITE PRURITUS (itching the injection site) and VACCINATION SITE ERYTHEMA (a little red at the injection site) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 012A21A) for COVID-19 vaccination. Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included INFLIXIMAB (REMICADE) for an unknown indication. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE NODULE (itching the injection site and it was a little red mark, had a knot), VACCINATION SITE PRURITUS (itching the injection site) and VACCINATION SITE ERYTHEMA (a little red at the injection site). At the time of the report, VACCINATION SITE NODULE (itching the injection site and it was a little red mark, had a knot), VACCINATION SITE PRURITUS (itching the injection site) and VACCINATION SITE ERYTHEMA (a little red at the injection site) outcome was unknown. Treatment information was not provided. Patient reported lack of side effects from the Remicade

Other Meds: REMICADE

Current Illness: Rheumatoid arthritis

ID: 1565212
Sex: M
Age: 62
State: GA

Vax Date: 03/09/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PHARYNGEAL SWELLING (Throat swelled up), DIZZINESS (Dizziness), ILLNESS (I was a sick sick puppy yesterday, chills were the worst, couldn't get warm), ASTHENIA (Weakness) and LYMPHADENOPATHY (Lymph nodes under the left arm were swollen) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PHARYNGEAL SWELLING (Throat swelled up), DIZZINESS (Dizziness), ILLNESS (I was a sick sick puppy yesterday, chills were the worst, couldn't get warm), ASTHENIA (Weakness), LYMPHADENOPATHY (Lymph nodes under the left arm were swollen), NAUSEA (Nausea), ARTHRALGIA (Joint pain), FATIGUE (Feeling really tired), HEADACHE (Head ache) and CHILLS (chills were the worst,). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency. At the time of the report, PHARYNGEAL SWELLING (Throat swelled up), DIZZINESS (Dizziness), ILLNESS (I was a sick sick puppy yesterday, chills were the worst, couldn't get warm), ASTHENIA (Weakness), LYMPHADENOPATHY (Lymph nodes under the left arm were swollen), NAUSEA (Nausea), ARTHRALGIA (Joint pain), FATIGUE (Feeling really tired), HEADACHE (Head ache) and CHILLS (chills were the worst,) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were not provided. Treatment with Aleve and Benadryl were provided.

Other Meds:

Current Illness:

ID: 1565213
Sex: F
Age:
State: TX

Vax Date: 03/10/2021
Onset Date: 03/11/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: sore arm, arm was hurting; fever; chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm, arm was hurting), PYREXIA (fever), CHILLS (chills) and NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm, arm was hurting), PYREXIA (fever), CHILLS (chills) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm, arm was hurting), PYREXIA (fever), CHILLS (chills) and NAUSEA (Nausea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided.

Other Meds:

Current Illness:

ID: 1565214
Sex: F
Age: 74
State: CA

Vax Date: 01/30/2021
Onset Date: 03/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: hard for her to breathe/hard time catching her breath; arm pain; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (hard for her to breathe/hard time catching her breath) and PAIN IN EXTREMITY (arm pain) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A20A and 043120A) for COVID-19 vaccination. No Medical History information was reported. On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced DYSPNOEA (hard for her to breathe/hard time catching her breath) and PAIN IN EXTREMITY (arm pain). At the time of the report, DYSPNOEA (hard for her to breathe/hard time catching her breath) and PAIN IN EXTREMITY (arm pain) outcome was unknown. No concomitant medication reported No treatment medication reported

Other Meds:

Current Illness:

ID: 1565215
Sex: M
Age: 67
State: MS

Vax Date: 01/19/2021
Onset Date: 03/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: upper respiratory issues; feels cold; has no appetite; chills; tired and fatigue; This spontaneous case was reported by a consumer and describes the occurrence of RESPIRATORY DISORDER (upper respiratory issues), FEELING COLD (feels cold), DECREASED APPETITE (has no appetite), CHILLS (chills) and FATIGUE (tired and fatigue) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20 and 042L20a) for COVID-19 vaccination. Concurrent medical conditions included Diabetes. Concomitant products included LISINOPRIL, ACETYLSALICYLIC ACID (ASPRIN), ROSUVASTATIN and INSULIN for an unknown indication. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced RESPIRATORY DISORDER (upper respiratory issues), FEELING COLD (feels cold), DECREASED APPETITE (has no appetite), CHILLS (chills) and FATIGUE (tired and fatigue). At the time of the report, RESPIRATORY DISORDER (upper respiratory issues), FEELING COLD (feels cold), DECREASED APPETITE (has no appetite), CHILLS (chills) and FATIGUE (tired and fatigue) outcome was unknown. Treatment information was not provided

Other Meds: LISINOPRIL; ASPRIN; ROSUVASTATIN; INSULIN

Current Illness:

ID: 1565216
Sex: F
Age: 81
State: NE

Vax Date: 03/05/2021
Onset Date: 03/06/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Feeling terrible; Muscle aches; This spontaneous case was reported by a patient and describes the occurrence of FEELING ABNORMAL (Feeling terrible) and MYALGIA (Muscle aches) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The patient's past medical history included COVID-19 in November 2020. Concomitant products included MELOXICAM for an unknown indication. On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced FEELING ABNORMAL (Feeling terrible) and MYALGIA (Muscle aches). At the time of the report, FEELING ABNORMAL (Feeling terrible) and MYALGIA (Muscle aches) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment information was not provided.

Other Meds: MELOXICAM

Current Illness:

ID: 1565217
Sex: F
Age:
State: OH

Vax Date: 03/09/2021
Onset Date: 03/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Numb tongue; Numb lips; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (Numb tongue) and HYPOAESTHESIA ORAL (Numb lips) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced HYPOAESTHESIA ORAL (Numb tongue) and HYPOAESTHESIA ORAL (Numb lips). On 09-Mar-2021, HYPOAESTHESIA ORAL (Numb tongue) and HYPOAESTHESIA ORAL (Numb lips) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications details were reported by the reporter. Treatment details was not reported by the reporter.

Other Meds:

Current Illness:

ID: 1565218
Sex: M
Age:
State: NC

Vax Date: 02/11/2021
Onset Date: 02/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (Pinkish on left arm of injection), VACCINATION SITE PRURITUS (Itchiness on left arm of injection), VACCINATION SITE PAIN (Tenderness left arm of injection) and VACCINATION SITE ERYTHEMA (Redness on left arm of injection) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. Concurrent medical conditions included Drug allergy. Concomitant products included METFORMIN for an unknown indication. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced VACCINATION SITE DISCOLOURATION (Pinkish on left arm of injection), VACCINATION SITE PRURITUS (Itchiness on left arm of injection), VACCINATION SITE PAIN (Tenderness left arm of injection) and VACCINATION SITE ERYTHEMA (Redness on left arm of injection). At the time of the report, VACCINATION SITE DISCOLOURATION (Pinkish on left arm of injection), VACCINATION SITE PRURITUS (Itchiness on left arm of injection), VACCINATION SITE PAIN (Tenderness left arm of injection) and VACCINATION SITE ERYTHEMA (Redness on left arm of injection) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient's concomitant medications include statin (unspecified).

Other Meds: METFORMIN

Current Illness:

ID: 1565219
Sex: F
Age: 85
State: FL

Vax Date: 03/05/2021
Onset Date: 03/06/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Dizziness; Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) and PYREXIA (Low grade fever) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. No Medical History information was reported. On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced DIZZINESS (Dizziness) and PYREXIA (Low grade fever). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 mg. On 06-Mar-2021, DIZZINESS (Dizziness) had resolved. At the time of the report, PYREXIA (Low grade fever) had resolved. No concomitant medication was reported. Action taken with mRNA-1273 in response to the event was not applicable.

Other Meds:

Current Illness:

ID: 1565220
Sex: F
Age: 76
State: FL

Vax Date: 02/27/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Can't Sleep; Itches; Huge Rash; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Can't Sleep), PRURITUS (Itches) and RASH (Huge Rash) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006N20A) for COVID-19 vaccination. No Medical History information was reported. On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced INSOMNIA (Can't Sleep), PRURITUS (Itches) and RASH (Huge Rash). At the time of the report, INSOMNIA (Can't Sleep), PRURITUS (Itches) and RASH (Huge Rash) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications was reported Treatment information included Cream

Other Meds:

Current Illness:

ID: 1565221
Sex: M
Age: 72
State:

Vax Date: 02/09/2021
Onset Date: 03/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: fever of 100 degrees Fahrenheit; This spontaneous case was reported by a physician and describes the occurrence of PYREXIA (fever of 100 degrees Fahrenheit) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included LOSARTAN and ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced PYREXIA (fever of 100 degrees Fahrenheit). The patient was treated with IBUPROFEN for Fever, at an unspecified dose and frequency. At the time of the report, PYREXIA (fever of 100 degrees Fahrenheit) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.

Other Meds: LOSARTAN; CRESTOR

Current Illness:

ID: 1565222
Sex: F
Age: 80
State: NJ

Vax Date: 03/10/2021
Onset Date: 03/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: arm was very sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was very sore) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. No Medical History information was reported. On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm was very sore). At the time of the report, PAIN IN EXTREMITY (arm was very sore) outcome was unknown. Not Provided No concomitant medications was reported Treatment information provided as "Ice" to treat the events

Other Meds:

Current Illness:

ID: 1565223
Sex: M
Age: 54
State: ND

Vax Date: 02/06/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: swollen lymph node under chin in throat; This spontaneous case was reported by a nurse and describes the occurrence of LYMPHADENOPATHY (swollen lymph node under chin in throat) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. No Medical History information was reported. On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (swollen lymph node under chin in throat). At the time of the report, LYMPHADENOPATHY (swollen lymph node under chin in throat) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. No treatment medication was reported.

Other Meds:

Current Illness:

ID: 1565224
Sex: F
Age: 72
State: NY

Vax Date: 02/04/2021
Onset Date: 02/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: high blood pressure; itchy at injection site; puffy at injection site; red at injection site; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (high blood pressure), VACCINATION SITE PRURITUS (itchy at injection site), VACCINATION SITE SWELLING (puffy at injection site) and VACCINATION SITE ERYTHEMA (red at injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. Concurrent medical conditions included Allergy NOS (carries an EpiPen). On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced HYPERTENSION (high blood pressure), VACCINATION SITE PRURITUS (itchy at injection site), VACCINATION SITE SWELLING (puffy at injection site) and VACCINATION SITE ERYTHEMA (red at injection site). At the time of the report, HYPERTENSION (high blood pressure) and VACCINATION SITE PRURITUS (itchy at injection site) outcome was unknown and VACCINATION SITE SWELLING (puffy at injection site) and VACCINATION SITE ERYTHEMA (red at injection site) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Blood pressure measurement: 90 to 150 (abnormal) blood pressure went from 90 to 150.. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications was reported. Treatment information was not provided. This case was linked to MOD-2021-210107 (Patient Link).

Other Meds:

Current Illness: Allergy NOS (carries an EpiPen)

ID: 1565225
Sex: F
Age: 71
State: MS

Vax Date: 03/09/2021
Onset Date: 03/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. Concomitant products included CLOPIDOGREL, METOPROLOL, ASPIRIN [ACETYLSALICYLIC ACID] and POTASSIUM for an unknown indication. On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm). On 11-Mar-2021, PAIN IN EXTREMITY (Pain in arm) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds: CLOPIDOGREL; METOPROLOL; ASPIRIN [ACETYLSALICYLIC ACID]; POTASSIUM

Current Illness:

ID: 1565226
Sex: M
Age: 26
State: LA

Vax Date: 03/11/2021
Onset Date: 03/11/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: vaccine administered from a vial punctured more than 18 hours ago; A spontaneous report was received from a pharmacist, concerning a 26-year-old male patient, who was administered Moderna's COVID-19 vaccine (mRNA-1273) and experienced vaccine administered from a vial punctured more than 18 hours ago/expired product administered. The patient's medical history and concomitant history wa not reported On 11 Mar 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: 027A21A) intramuscularly in left arm for prophylaxis of COVID-19 infection. On 11 Mar 2021, the patient received a dose the Moderna COVID-19 vaccine that had been previous punctured more than 18 hours prior to his vaccination. The Action taken with the first dose of mRNA-1273 in response to the event was unknown. The outcome of the event, vaccine administered from a vial punctured more than 18 hours ago/expired product administered, was considered resolved on 11 Mar 2021.; Reporter's Comments: This report refers to a case of expired product administered for mRNA-1273 with no associated AEs.

Other Meds:

Current Illness:

ID: 1565227
Sex: F
Age:
State: OH

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Dizzy; Weak; Sick; Nauseated; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), ASTHENIA (Weak), ILLNESS (Sick) and NAUSEA (Nauseated) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizzy), ASTHENIA (Weak), ILLNESS (Sick) and NAUSEA (Nauseated). At the time of the report, DIZZINESS (Dizzy), ASTHENIA (Weak), ILLNESS (Sick) and NAUSEA (Nauseated) outcome was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1565228
Sex: M
Age: 75
State: LA

Vax Date: 03/09/2021
Onset Date: 03/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: soreness, aches, pains; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (soreness, aches, pains) and FATIGUE (fatigue) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00-B21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced PAIN (soreness, aches, pains) and FATIGUE (fatigue). At the time of the report, PAIN (soreness, aches, pains) and FATIGUE (fatigue) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant and treatment details were provided. treatment to the events not provided.

Other Meds:

Current Illness:

ID: 1565229
Sex: F
Age:
State: AL

Vax Date: 03/05/2021
Onset Date: 03/06/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. No Medical History information was reported. On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced DIARRHOEA (Diarrhea). The patient was treated with LOPERAMIDE HYDROCHLORIDE (PEPTO DIARRHEA CONTROL) on 06-Mar-2021 at an unspecified dose and frequency. At the time of the report, DIARRHOEA (Diarrhea) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications was reported

Other Meds:

Current Illness:

ID: 1565230
Sex: U
Age: 31
State: NC

Vax Date: 03/08/2021
Onset Date: 03/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: pain was sever and tender to touch.; fever with temperature of 99.4; chills; arm pain, couldn't move or lift his arm above 45 degrees; flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain, couldn't move or lift his arm above 45 degrees), INFLUENZA LIKE ILLNESS (flu like symptoms), TENDERNESS (pain was sever and tender to touch.), PYREXIA (fever with temperature of 99.4) and CHILLS (chills) in a 31-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. No Medical History information was reported. On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm pain, couldn't move or lift his arm above 45 degrees), INFLUENZA LIKE ILLNESS (flu like symptoms), PYREXIA (fever with temperature of 99.4) and CHILLS (chills). On an unknown date, the patient experienced TENDERNESS (pain was sever and tender to touch.). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm pain, couldn't move or lift his arm above 45 degrees), INFLUENZA LIKE ILLNESS (flu like symptoms), TENDERNESS (pain was sever and tender to touch.), PYREXIA (fever with temperature of 99.4) and CHILLS (chills) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Mar-2021, Body temperature: 99.4 (High) temperature of 99.4. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided.

Other Meds:

Current Illness:

ID: 1565231
Sex: M
Age: 50
State:

Vax Date: 03/08/2021
Onset Date: 03/11/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: dry skin all over the top part of head; This spontaneous case was reported by a consumer and describes the occurrence of DRY SKIN (dry skin all over the top part of head) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was reported by the reporter. Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) and FENOFIBRATE for an unknown indication. On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced DRY SKIN (dry skin all over the top part of head). At the time of the report, DRY SKIN (dry skin all over the top part of head) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The patient provided lot number as 013A21A or 013A214. Treatment include Soap.

Other Meds: CRESTOR; FENOFIBRATE

Current Illness:

ID: 1565232
Sex: F
Age: 78
State: GA

Vax Date: 02/12/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: dizziness; head spinning; This spontaneous case was reported by a patient and describes the occurrence of DIZZINESS (dizziness) and VERTIGO (head spinning) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M21A) for COVID-19 vaccination. No Medical History information was reported. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness) and VERTIGO (head spinning). At the time of the report, DIZZINESS (dizziness) had not resolved and VERTIGO (head spinning) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Additional information received captured event outcome.

Other Meds:

Current Illness:

ID: 1565233
Sex: F
Age: 69
State: LA

Vax Date: 02/26/2021
Onset Date: 02/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: rash on her abdomen; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on her abdomen) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. Concurrent medical conditions included Allergy to antibiotic. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced RASH (rash on her abdomen). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash, at a dose of 1 dosage form. At the time of the report, RASH (rash on her abdomen) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported by the reporter.

Other Meds:

Current Illness: Allergy to antibiotic

ID: 1565234
Sex: F
Age: 66
State: FL

Vax Date: 03/01/2021
Onset Date: 03/06/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: stomach pain; Chills; headache; nausea; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach pain), CHILLS (Chills), HEADACHE (headache) and NAUSEA (nausea) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. No Medical History information was reported. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach pain), CHILLS (Chills), HEADACHE (headache) and NAUSEA (nausea). At the time of the report, ABDOMINAL PAIN UPPER (stomach pain), CHILLS (Chills), HEADACHE (headache) and NAUSEA (nausea) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1565235
Sex: F
Age:
State: MD

Vax Date: 02/10/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Sore arm; Feeling tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and FATIGUE (Feeling tired) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 012A214) for COVID-19 vaccination. No medical history was reported by the reporter. Concomitant products included CARBIDOPA, LEVODOPA (LEVODOPA/CARBIDOPA), INSULIN, ESCITALOPRAM OXALATE (LEXAPRO), COLECALCIFEROL (VITAMIN D 3), ACETYLSALICYLIC ACID (BABY ASPIRIN), RIVASTIGMINE, SIMVASTATIN, MELATONIN, CALCIUM LEVOMEFOLATE (DEPLIN [CALCIUM LEVOMEFOLATE]) and MULTI VIT for an unknown indication. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm) and FATIGUE (Feeling tired). At the time of the report, PAIN IN EXTREMITY (Sore arm) and FATIGUE (Feeling tired) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided. This case was linked to MOD21-051280 (Patient Link).

Other Meds: LEVODOPA/CARBIDOPA; INSULIN; LEXAPRO; VITAMIN D 3; BABY ASPIRIN; RIVASTIGMINE; SIMVASTATIN; MELATONIN; DEPLIN [CALCIUM LEVOMEFOLATE]; MULTI VIT

Current Illness:

ID: 1565236
Sex: M
Age:
State: OH

Vax Date: 03/10/2021
Onset Date: 03/11/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: dizziness; soreness at the site of injection in his left (nondominant) arm.; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness) and VACCINATION SITE PAIN (soreness at the site of injection in his left (nondominant) arm.) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Diabetes. On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced DIZZINESS (dizziness) and VACCINATION SITE PAIN (soreness at the site of injection in his left (nondominant) arm.). At the time of the report, DIZZINESS (dizziness) and VACCINATION SITE PAIN (soreness at the site of injection in his left (nondominant) arm.) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use included unspecified diabetes medication daily. No treatment information was provided.

Other Meds:

Current Illness: Diabetes

ID: 1565237
Sex: F
Age: 53
State: VA

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: COVID Arm; COVID Arm (red, hard, itchy); COVID Arm (red, hard, itchy); COVID Arm (red, hard, itchy); Sore arm; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (Sore arm), VACCINATION SITE REACTION (COVID Arm), VACCINATION SITE INDURATION (COVID Arm (red, hard, itchy)), VACCINATION SITE PRURITUS (COVID Arm (red, hard, itchy)) and VACCINATION SITE ERYTHEMA (COVID Arm (red, hard, itchy)) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 004M20A) for COVID-19 vaccination. The patient's past medical history included Genital herpes (Genital herpes IgG was Positive IgM was negative) in 2005. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 20-Jan-2021, the patient experienced VACCINATION SITE REACTION (COVID Arm), VACCINATION SITE INDURATION (COVID Arm (red, hard, itchy)), VACCINATION SITE PRURITUS (COVID Arm (red, hard, itchy)) and VACCINATION SITE ERYTHEMA (COVID Arm (red, hard, itchy)). On 12-Jan-2021, PAIN IN EXTREMITY (Sore arm) had resolved. On 21-Jan-2021, VACCINATION SITE REACTION (COVID Arm), VACCINATION SITE INDURATION (COVID Arm (red, hard, itchy)), VACCINATION SITE PRURITUS (COVID Arm (red, hard, itchy)) and VACCINATION SITE ERYTHEMA (COVID Arm (red, hard, itchy)) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. No treatment information was provided. This case was linked to MOD-2021-207871 (Patient Link).

Other Meds:

Current Illness:

ID: 1565238
Sex: F
Age: 76
State: NC

Vax Date: 03/05/2021
Onset Date: 03/05/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Palms have been glowing red; left leg hurts really hurts; body aches; slight headache; teeth, lip and tongue are numb; Felt something in mouth but didn't manifest them; uncomfortable; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DISCOMFORT (uncomfortable), HYPOAESTHESIA ORAL (teeth, lip and tongue are numb), FEELING ABNORMAL (Felt something in mouth but didn't manifest them), ERYTHEMA (Palms have been glowing red) and PAIN IN EXTREMITY (left leg hurts really hurts) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Blood pressure abnormal and Heart rate irregular. Concomitant products included APIXABAN (ELIQUIS) for Anticoagulant therapy, METOPROLOL for Blood pressure abnormal and Heart rate irregular, ENALAPRIL for Heartbeats irregular, POTASSIUM, MAGNESIUM, VITAMIN B COMPLEX and ASCORBIC ACID (VIT C) for an unknown indication. On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced DISCOMFORT (uncomfortable) and FEELING ABNORMAL (Felt something in mouth but didn't manifest them). On 06-Mar-2021, the patient experienced HYPOAESTHESIA ORAL (teeth, lip and tongue are numb). On an unknown date, the patient experienced ERYTHEMA (Palms have been glowing red), PAIN IN EXTREMITY (left leg hurts really hurts), MYALGIA (body aches) and HEADACHE (slight headache). The patient was treated with PARACETAMOL (TYLENOL) for Myalgia and Leg pain, at a dose of 1 dosage form. At the time of the report, DISCOMFORT (uncomfortable), HYPOAESTHESIA ORAL (teeth, lip and tongue are numb) and FEELING ABNORMAL (Felt something in mouth but didn't manifest them) had not resolved and ERYTHEMA (Palms have been glowing red), PAIN IN EXTREMITY (left leg hurts really hurts), MYALGIA (body aches) and HEADACHE (slight headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Additional information received captured no new information.

Other Meds: ELIQUIS; ENALAPRIL; METOPROLOL; POTASSIUM; MAGNESIUM; VITAMIN B COMPLEX; VIT C

Current Illness: Blood pressure abnormal; Heart rate irregular

ID: 1565239
Sex: F
Age: 81
State: NC

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Itching all over body; Redness; Chills; Arm was sore; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (Itching all over body), ERYTHEMA (Redness), PAIN IN EXTREMITY (Arm was sore) and CHILLS (Chills) in an 81-year-old female patient who received mRNA-1273 (batch no. 014M20A) for COVID-19 vaccination. Concurrent medical conditions included Chronic kidney disease stage 4. Concomitant products included TORSEMIDE, ALLOPURINOL, DILTIAZEM, MONTELUKAST, GABAPENTIN, ESCITALOPRAM, PRAVASTATIN, PRAMIPEXOLE, CALCIUM CARBONATE (CALTRATE [CALCIUM CARBONATE]), PARACETAMOL (TYLENOL), VITAMIN D3 and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore). On 08-Mar-2021, the patient experienced PRURITUS (Itching all over body), ERYTHEMA (Redness) and CHILLS (Chills). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of UNK dosage form. At the time of the report, PRURITUS (Itching all over body), ERYTHEMA (Redness), PAIN IN EXTREMITY (Arm was sore) and CHILLS (Chills) outcome was unknown. The action taken with mRNA-1273 (Intramuscular) was unknown. For her symptoms her doctor told her use ice packs.

Other Meds: TORSEMIDE; ALLOPURINOL; DILTIAZEM; MONTELUKAST; GABAPENTIN; ESCITALOPRAM; PRAVASTATIN; PRAMIPEXOLE; CALTRATE [CALCIUM CARBONATE]; TYLENOL; VITAMIN D3; ASPIRIN [ACETYLSALICYLIC ACID]

Current Illness: Chronic kidney disease stage 4

ID: 1565240
Sex: F
Age:
State: NE

Vax Date: 03/09/2021
Onset Date: 03/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Next morning diarrhea; Next morning for 2 hours nausea; Fatigue that day; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Next morning diarrhea), FATIGUE (Fatigue that day) and NAUSEA (Next morning for 2 hours nausea) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. Concurrent medical conditions included Sleep disorder NOS. Concomitant products included TRAZODONE for Sleep disorder NOS, FLUOXETINE HYDROCHLORIDE (PROZAC), LAMOTRIGINE (LAMICTAL) and VITAMIN B COMPLEX for an unknown indication. On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced FATIGUE (Fatigue that day). On 10-Mar-2021, the patient experienced DIARRHOEA (Next morning diarrhea) and NAUSEA (Next morning for 2 hours nausea). On 09-Mar-2021, FATIGUE (Fatigue that day) had resolved. On 10-Mar-2021, NAUSEA (Next morning for 2 hours nausea) had resolved. At the time of the report, DIARRHOEA (Next morning diarrhea) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The patient took coffee for fatigue and it went away.

Other Meds: PROZAC; LAMICTAL; VITAMIN B COMPLEX; TRAZODONE

Current Illness: Sleep disorder NOS

ID: 1565241
Sex: F
Age: 59
State: NY

Vax Date: 01/04/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: unable to complete the vaccination series; tennis elbow; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (unable to complete the vaccination series) and EPICONDYLITIS (tennis elbow) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The patient's past medical history included Mitral valve prolapse (asymptomatic). Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81) and VITAMINS NOS for an unknown indication. On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (unable to complete the vaccination series) and EPICONDYLITIS (tennis elbow). At the time of the report, PRODUCT DOSE OMISSION ISSUE (unable to complete the vaccination series) had resolved and EPICONDYLITIS (tennis elbow) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. The patient was prescribed unspecified steroids for tennis elbow.

Other Meds: ASPIRIN 81; VITAMINS NOS

Current Illness:

ID: 1565242
Sex: F
Age:
State:

Vax Date: 03/10/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1565243
Sex: F
Age:
State: MD

Vax Date: 02/10/2021
Onset Date: 03/11/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: some redness and itching on wrist and side of her fingers; some redness and itching on wrist and side of her fingers; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (some redness and itching on wrist and side of her fingers) and PRURITUS (some redness and itching on wrist and side of her fingers) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A214 and 030M20A) for COVID-19 vaccination. No medical history was reported by the reporter. Concomitant products included CARBIDOPA, LEVODOPA (LEVODOPA/CARBIDOPA), INSULIN, ESCITALOPRAM OXALATE (LEXAPRO), CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), ACETYLSALICYLIC ACID (BABY ASPIRIN), RIVASTIGMINE, SIMVASTATIN, CALCIUM LEVOMEFOLATE (DEPLIN [CALCIUM LEVOMEFOLATE]), MELATONIN and MULTIVITAMIN [VITAMINS NOS] for an unknown indication. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced ERYTHEMA (some redness and itching on wrist and side of her fingers) and PRURITUS (some redness and itching on wrist and side of her fingers). At the time of the report, ERYTHEMA (some redness and itching on wrist and side of her fingers) and PRURITUS (some redness and itching on wrist and side of her fingers) outcome was unknown. No treatment information was provided. This case was linked to MOD21-051280 (Patient Link).

Other Meds: LEVODOPA/CARBIDOPA; INSULIN; LEXAPRO; VITAMIN D 2000; BABY ASPIRIN; RIVASTIGMINE; SIMVASTATIN; DEPLIN [CALCIUM LEVOMEFOLATE]; MELATONIN; MULTIVITAMIN [VITAMINS NOS]

Current Illness:

ID: 1565244
Sex: M
Age: 50
State: CA

Vax Date: 03/08/2021
Onset Date: 03/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Pain on arm; pain on his arm and difficulty moving it; Chills; Headaches; Fatigue; Swelling on his armpit; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain on arm), LIMB DISCOMFORT (pain on his arm and difficulty moving it), SWELLING (Swelling on his armpit), CHILLS (Chills) and HEADACHE (Headaches) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A2PA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Diabetes and Cholesterol. On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced SWELLING (Swelling on his armpit). On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain on arm), LIMB DISCOMFORT (pain on his arm and difficulty moving it), CHILLS (Chills), HEADACHE (Headaches) and FATIGUE (Fatigue). The patient was treated with IBUPROFEN at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (Pain on arm), LIMB DISCOMFORT (pain on his arm and difficulty moving it), SWELLING (Swelling on his armpit), CHILLS (Chills), HEADACHE (Headaches) and FATIGUE (Fatigue) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concurrent medical conditions included Diabetes and Cholesterol.

Other Meds:

Current Illness: Cholesterol; Diabetes

ID: 1565245
Sex: F
Age:
State:

Vax Date:
Onset Date: 03/11/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: 50 days between first and second dose; This spontaneous case was reported by an other health care professional and describes the occurrence of OFF LABEL USE (50 days between first and second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced OFF LABEL USE (50 days between first and second dose). At the time of the report, OFF LABEL USE (50 days between first and second dose) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was included. No treatment medication was provided. Rescheduling was not made on time so the second dose passed the 42 days limit.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 704,237

Page last modified: 26 October 2021 2:21am